Nova Allegro HbA1c Assay, Nova Allegro Analyzer— 510(k) K221326
Substantially EquivalentNova Biomedical Corporation
FDA 510(k) clearance K221326 for Nova Allegro HbA1c Assay, Nova Allegro Analyzer, Substantially Equivalent on 2024-11-22. Applicant: Nova Biomedical Corporation.
Clearance details
- Applicant
- Nova Biomedical Corporation
- Product code
- Code LCP
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Dual Track
- Location
- Walham, MA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.